These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 172453)

  • 1. Neuropathological effects of persistent infection of mice by mouse hepatitis virus.
    Virelizier JL; Dayan AD; Allison AC
    Infect Immun; 1975 Nov; 12(5):1127-40. PubMed ID: 172453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection.
    Prévost CL; Virelizier JL; Dupuy JM
    J Immunol; 1975 Sep; 115(3):640-3. PubMed ID: 168262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in response of susceptible mouse strains to a small plaque mutant (JHM-CC) of mouse coronavirus.
    Hirano N; Tsukamoto T; Haga S; Iwasaki Y
    Adv Exp Med Biol; 1990; 276():617-20. PubMed ID: 1966457
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells.
    Tardieu M; Boespflug O; Barbé T
    J Virol; 1986 Nov; 60(2):574-82. PubMed ID: 3021991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice.
    Woyciechowska JL; Trapp BD; Patrick DH; Shekarchi IC; Leinikki PO; Sever JL; Holmes KV
    J Exp Pathol; 1984; 1(4):295-306. PubMed ID: 6100984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental demyelination produced by the A59 strain of mouse hepatitis virus.
    Lavi E; Gilden DH; Wroblewska Z; Rorke LB; Weiss SR
    Neurology; 1984 May; 34(5):597-603. PubMed ID: 6324031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.
    Lamontagne LM; Dupuy JM
    Infect Immun; 1984 Jun; 44(3):716-23. PubMed ID: 6327531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
    Lamontagne L; Descoteaux JP; Jolicoeur P
    J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A on an experimental chronic viral infection of the central nervous system.
    Boespflug O; Godfraind C; Tardieu M
    J Neuroimmunol; 1989 Jan; 21(1):49-57. PubMed ID: 2535702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination.
    Wang FI; Hinton DR; Gilmore W; Trousdale MD; Fleming JO
    Lab Invest; 1992 Jun; 66(6):744-54. PubMed ID: 1318460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of mouse hepatitis virus type 3 infection. IV. MHV3-induced immunodepression.
    Leray D; Dupuy C; Dupuy JM
    Clin Immunol Immunopathol; 1982 May; 23(2):539-47. PubMed ID: 6286197
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphokine release as measurement of anti-mouse hepatitis virus type 3 (MHV3) cellular reactions in various mouse lines exhibiting differential susceptibilities to MHV3-induced paralysis.
    Mansour S; Mercier G; Oth D
    Acta Virol; 1990 Sep; 34(5):423-32. PubMed ID: 1981453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB.
    Stoica G; Illanes O; Tasca SI; Wong PK
    Lab Invest; 1993 Dec; 69(6):724-35. PubMed ID: 8264234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell tropisms of attenuated MHV3 viruses isolated from brains of chronically infected mice.
    Lamontagne L; Décarie D; Jolicoeur P
    Viral Immunol; 1990; 3(1):1-8. PubMed ID: 2153384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent in vitro infection with mouse hepatitis virus 3.
    Lamontagne L; Dupuy JM
    Adv Exp Med Biol; 1984; 173():315-26. PubMed ID: 6331121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis.
    Das Sarma J; Fu L; Hingley ST; Lavi E
    Exp Mol Pathol; 2001 Aug; 71(1):1-12. PubMed ID: 11502093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis.
    Lehoux M; Jacques A; Lusignan S; Lamontagne L
    Clin Exp Immunol; 2004 Jul; 137(1):41-51. PubMed ID: 15196242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte-dependent difference in susceptibility between DDD and C3H mice to mouse hepatitis virus, MHV-3.
    Yamada A; Taguchi F; Fujiwara K
    Jpn J Exp Med; 1979 Dec; 49(6):413-21. PubMed ID: 232196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
    Jolicoeur P; Lamontagne L
    J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.